Free Trial

Fulcrum Therapeutics (FULC) Short Interest Ratio & Short Volume

Fulcrum Therapeutics logo
$3.26
+0.05 (+1.56%)
(As of 11/4/2024 ET)

Fulcrum Therapeutics Short Interest Data

Fulcrum Therapeutics (FULC) has a short interest of 5.52 million shares. This marks a -6.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 991,858 shares to cover all short positions.

Current Short Interest
5,520,000 shares
Previous Short Interest
5,900,000 shares
Change Vs. Previous Month
-6.44%
Dollar Volume Sold Short
$20.20 million
Short Interest Ratio
3.3 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
62,400,000 shares
Percentage of Shares Shorted
8.85%
Today's Trading Volume
843,613 shares
Average Trading Volume
991,858 shares
Today's Volume Vs. Average
85%
Short Selling Fulcrum Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Fulcrum Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FULC Short Interest Over Time

FULC Days to Cover Over Time

FULC Percentage of Float Shorted Over Time

Fulcrum Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20245,520,000 shares $20.20 million -6.4%N/A3.3 $3.66
9/30/20245,900,000 shares $21.06 million -48.3%N/A3.5 $3.57
9/15/202411,400,000 shares $36.25 million +41.4%N/A6.8 $3.18
8/31/20248,060,000 shares $68.91 million -1.1%N/A8.7 $8.55
8/15/20248,150,000 shares $78.97 million +6.1%N/A9 $9.69
7/31/20247,680,000 shares $71.27 million +5.8%N/A8.8 $9.28
7/15/20247,260,000 shares $61.35 million +37.2%N/A9.3 $8.45
6/30/20245,290,000 shares $32.80 million +36.3%N/A7.2 $6.20
6/15/20243,880,000 shares $28.91 million +8.1%N/A6.8 $7.45
5/31/20243,590,000 shares $28.18 million +16.2%N/A6.7 $7.85
5/15/20243,090,000 shares $25.49 million +3.0%N/A5 $8.25
4/30/20243,000,000 shares $21.39 million +18.6%N/A5 $7.13
4/15/20242,530,000 shares $18.62 million +12.0%N/A4 $7.36
3/31/20242,260,000 shares $21.33 million -5.4%N/A3.4 $9.44
3/15/20242,390,000 shares $27.15 million -25.3%N/A3.4 $11.36
2/29/20243,200,000 shares $32.67 million -0.6%N/A4.5 $10.21
2/15/20243,220,000 shares $30.27 million -4.7%N/A5.1 $9.40
1/31/20243,380,000 shares $24.40 million -16.3%N/A5.5 $7.22
1/15/20244,040,000 shares $28.68 million +10.1%N/A6.7 $7.10
12/31/20233,670,000 shares $24.77 million +10.2%N/A6.5 $6.75
12/15/20233,330,000 shares $17.95 million -18.0%N/A6.2 $5.39
11/30/20234,060,000 shares $19.49 million +9.7%N/A7.8 $4.80
11/15/20233,700,000 shares $15.47 million -6.3%N/A6.1 $4.18
10/31/20233,950,000 shares $14.38 million +1.0%N/A2 $3.64
10/15/20233,910,000 shares $15.21 million -2.7%N/A1.9 $3.89
9/30/20234,020,000 shares $17.85 million +7.5%N/A2 $4.44
9/15/20233,740,000 shares $16.79 million +5.1%N/A1.8 $4.49
8/31/20233,560,000 shares $19.69 million +30.4%N/A1.7 $5.53
8/15/20232,730,000 shares $11.55 million -22.2%N/A1.3 $4.23
7/31/20233,510,000 shares $13.41 million +0.3%N/A5 $3.82
7/15/20233,500,000 shares $12.88 million -4.1%N/A4.6 $3.68
6/30/20233,650,000 shares $12.05 million -19.3%N/A4.6 $3.30
6/15/20234,520,000 shares $13.74 million +9.4%N/A5.3 $3.04
5/31/20234,130,000 shares $11.23 million +4.8%N/A4.1 $2.72
5/15/20233,940,000 shares $14.34 million -17.6%N/A3.2 $3.64
4/30/20234,780,000 shares $11.95 million -6.6%N/A3.9 $2.50
4/15/20235,120,000 shares $12.34 million +3.6%N/A4.2 $2.41
3/31/20234,940,000 shares $14.08 million +25.1%N/A3.8 $2.85
3/15/20233,950,000 shares $15.01 million -2.5%N/A3.1 $3.80
2/28/20234,050,000 shares $24.46 million +7.7%N/A3.8 $6.04
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
2/15/20233,760,000 shares $48.69 million +6.2%N/A3.8 $12.95
1/31/20233,540,000 shares $44.64 million +6.6%N/A4.6 $12.61
1/15/20233,320,000 shares $45.48 million -7.3%N/A4.6 $13.70
12/30/20223,580,000 shares $26.06 million +21.0%N/A5.7 $7.28
12/15/20222,960,000 shares $16.22 million -9.2%N/A6.1 $5.48
11/30/20223,260,000 shares $22.33 million -4.4%N/A8.5 $6.85
11/15/20223,410,000 shares $24.48 million -2.0%N/A8.9 $7.18
10/31/20223,480,000 shares $19.35 million +0.6%N/A8 $5.56
10/15/20223,460,000 shares $25.95 million -3.9%N/A7.5 $7.50
9/30/20223,600,000 shares $29.12 million -7.2%N/A8.4 $8.09
9/15/20223,880,000 shares $35.31 million +13.8%N/A8.4 $9.10
8/31/20223,410,000 shares $25.23 million +5.3%N/A5.3 $7.40
8/15/20223,240,000 shares $25.34 million -8.2%N/A4.6 $7.82
7/31/20223,530,000 shares $20.76 million -6.1%12.0%4.8 $5.88
7/15/20223,760,000 shares $20.27 million +1.4%12.8%5.1 $5.39
6/30/20223,710,000 shares $18.18 million +6.6%12.6%4.3 $4.90
6/15/20223,480,000 shares $15.35 million -7.0%11.8%3.9 $4.41
5/31/20223,740,000 shares $26.63 million +9.4%12.7%5 $7.12
5/15/20223,420,000 shares $28.32 million -21.7%11.6%4.7 $8.28
4/30/20224,370,000 shares $42.04 million +63.1%15.1%6.4 $9.62
4/15/20222,680,000 shares $35.48 million -0.4%9.3%4.4 $13.24
3/31/20222,690,000 shares $63.62 million -5.0%9.3%5.4 $23.65
3/15/20222,830,000 shares $44.52 million +12.8%9.8%6.6 $15.73
2/28/20222,510,000 shares $27.61 million -4.9%8.4%6 $11.00
2/15/20222,640,000 shares $29.81 million +25.7%8.8%6.5 $11.29
1/31/20222,100,000 shares $25.54 million +17.3%7.2%4.7 $12.16
1/15/20221,790,000 shares $24.92 million -2.7%N/A0 $13.92
12/31/20211,840,000 shares $32.55 million +8.2%6.1%4.1 $17.69
12/15/20211,700,000 shares $28.56 million -18.7%5.6%3.4 $16.80
11/30/20212,090,000 shares $30.31 million -31.0%6.9%3.9 $14.50
11/15/20213,030,000 shares $54.12 million +47.1%10.0%5.5 $17.86
10/29/20212,060,000 shares $45.61 million -0.5%6.9%0.6 $22.14
10/15/20212,070,000 shares $53.82 million +0.5%6.8%0.6 $26.00
9/30/20212,060,000 shares $58.11 million +21.2%6.7%0.6 $28.21
9/15/20211,700,000 shares $45.85 million +4.9%5.9%0.5 $26.97
8/31/20211,620,000 shares $48.11 million -35.5%6.2%0.5 $29.70
8/13/20212,510,000 shares $57.55 million +261.2%13.1%0.8 $22.93
7/30/2021695,000 shares $5.08 million -7.4%4.4%0.4 $7.31
7/15/2021750,400 shares $7.02 million -12.2%4.7%4.9 $9.36
6/30/2021855,000 shares $8.96 million +29.1%5.4%6 $10.48
6/15/2021662,500 shares $5.59 million -2.4%4.2%5.9 $8.44
5/28/2021678,600 shares $6.06 million -5.4%4.3%7.7 $8.93
5/14/2021717,100 shares $7.09 million -3.6%4.5%8 $9.89
4/30/2021743,500 shares $8.35 million -3.6%4.8%7.4 $11.23
4/15/2021771,100 shares $9.23 million +0.5%3.6%6.4 $11.97
3/31/2021767,600 shares $8.77 million +8.9%3.6%5.4 $11.43
3/15/2021705,000 shares $8.62 million +2.0%3.3%4.6 $12.22
2/26/2021691,000 shares $8.82 million -4.6%3.2%4.6 $12.77
2/12/2021724,100 shares $9.70 million +2.4%3.5%4.5 $13.40
1/29/2021707,500 shares $7.96 million -21.8%4.1%4.3 $11.25
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
1/15/2021904,800 shares $10.27 million -9.5%5.3%5.3 $11.35
12/31/20201,000,000 shares $12.69 million +13.2%6.8%6 $12.69
12/15/2020883,700 shares $11.80 million -5.1%6.0%4.7 $13.35
11/30/2020931,000 shares $10.74 million -9.6%6.3%4.6 $11.54
11/15/20201,030,000 shares $13.03 million -22.0%7.0%5.1 $12.65
10/30/20201,320,000 shares $13.11 million +9.1%9.7%5.5 $9.93
10/15/20201,210,000 shares $13.64 million +5.2%8.9%5 $11.27
9/30/20201,150,000 shares $9.12 million +34.6%8.5%5.4 $7.93
9/15/2020854,200 shares $6.65 million +14.7%6.3%4.3 $7.78
8/31/2020745,000 shares $5.42 million +91.8%5.5%4.2 $7.27
8/14/2020388,400 shares $2.96 million -22.2%2.9%2.5 $7.62
7/31/2020499,200 shares $7.92 million +6.1%3.6%4.4 $15.87
7/15/2020470,600 shares $8.31 million -37.3%3.4%5.5 $17.66
6/30/2020751,000 shares $13.74 million +35.6%6.5%9 $18.29
6/15/2020553,700 shares $9.62 million +2.1%5.6%6.6 $17.37
5/29/2020542,600 shares $10.80 million -0.9%5.5%6.2 $19.91
5/15/2020547,400 shares $9.14 million -6.8%5.6%6 $16.69
4/30/2020587,200 shares $7.41 million +2.3%6.3%6.9 $12.62
4/15/2020574,300 shares $6.23 million +23.4%6.2%6.5 $10.85
3/31/2020465,400 shares $5.25 million +74.3%5.0%4.8 $11.29
3/13/2020267,000 shares $2.83 million +17.4%N/A3.8 $10.60
2/28/2020227,400 shares $2.16 million +26.7%N/A3.3 $9.49
2/14/2020179,500 shares $2.33 million +29.9%1.9%2.6 $13.00
1/31/2020138,200 shares $2.53 million +16.1%1.5%2 $18.29
1/15/2020119,000 shares $1.93 million +19.6%1.3%1.8 $16.20
12/31/201999,500 shares $1.69 million -54.2%1.1%1.5 $17.00

FULC Short Interest - Frequently Asked Questions

What is Fulcrum Therapeutics' current short interest?

Short interest is the volume of Fulcrum Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 5,520,000 shares of FULC short. Learn More on Fulcrum Therapeutics' current short interest.

What is a good short interest ratio for Fulcrum Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FULC shares currently have a short interest ratio of 3.0. Learn More on Fulcrum Therapeutics's short interest ratio.

Which institutional investors are shorting Fulcrum Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fulcrum Therapeutics: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Fulcrum Therapeutics' short interest increasing or decreasing?

Fulcrum Therapeutics saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 5,520,000 shares, a decrease of 6.4% from the previous total of 5,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Fulcrum Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Fulcrum Therapeutics: Sangamo Therapeutics, Inc. (8.75%), Kezar Life Sciences, Inc. (16.30%), bluebird bio, Inc. (25.49%), 89bio, Inc. (5.47%), Arbutus Biopharma Co. (4.13%), Replimune Group, Inc. (10.48%), CorMedix Inc. (12.95%), Aligos Therapeutics, Inc. (3.68%), Immunome, Inc. (22.29%), Annexon, Inc. (8.44%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Fulcrum Therapeutics stock?

Short selling FULC is an investing strategy that aims to generate trading profit from Fulcrum Therapeutics as its price is falling. FULC shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fulcrum Therapeutics?

A short squeeze for Fulcrum Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FULC, which in turn drives the price of the stock up even further.

How often is Fulcrum Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FULC, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:FULC) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners